Selective antileishmania activity of 13,28-epoxy-oleanane and related triterpene saponins from the plant families Myrsinaceae, Primulaceae, Aceraceae and Icacinaceae

Phytotherapy Research

Volumn 23, Issue 10, 2009, Pages 1404-1410

  Vermeersch, Marieke ^a   Foubert, Kenn ^a   Da Luz, Raquel Inocêncio ^a   Van Puyvelde, Luc ^b   Pieters, Luc ^a   Cos, Paul ^a   Maes, Louis ^a,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b INSTITUTE OF CHEMISTRY   (Viet Nam)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

13,28 epoxy oleanane triterpene saponins; Aceraceae; Icacinaceae; Leishmania infantum; Myrsinaceae; Primulaceae

Indexed keywords

13,28 EPOXY OLEANANE TRITERPENE; ANTILEISHMANIAL AGENT; PLANT EXTRACT; SAPONIN; TRITERPENE; UNCLASSIFIED DRUG;

ACER; ACERACEAE; AMASTIGOTE; ANAGALLIS; ANIMAL CELL; ANIMAL EXPERIMENT; APODYTES; ARDISIA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; LEISHMANIA INFANTUM; LYSIMACHIA; MAESA; MOUSE; MYRSINACEAE; MYRSINE; NONHUMAN; PLANT LEAF; PLANT ROOT; PRIMULACEAE; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANGIOSPERMS; ANIMALS; ANTIPARASITIC AGENTS; CELL LINE; FIBROBLASTS; HUMANS; LEISHMANIA INFANTUM; MACROPHAGES; MICE; MICE, INBRED STRAINS; MICROBIAL SENSITIVITY TESTS; MYRSINACEAE; OLEANOLIC ACID; PLANT EXTRACTS; SAPONINS; STRUCTURE-ACTIVITY RELATIONSHIP;

ACER; ACER LAURINUM; ARDISIA; ARDISIA GIGANTIFOLIA; ICACINACEAE; LEISHMANIA INFANTUM; MAESA; MYRSINACEAE; MYRSINE; PRIMULACEAE; SAPINDACEAE;

EID: 70349941546     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2788     Document Type: Article

References (30)

1. Amoros M, Fauconnier B, Girre RL. 1987. In vitro antiviral activity of a saponin from Anagallis arvensis against herpes simplex virus and poliovirus. Antiviral Res 8: 13-25.
2. Apers S, Baronikova S, Sindambiwe J-B et al. 2001. Antiviral, haemolytic and molluscicidal effects of triterpenoid saponins from Maesa lanceolata: Establishment of structure-activity relationships. Planta Med 67: 528-532. (Pubitemid 32800418)
3. Apers S, De Bruyne T, Claeys M, Vlietinck AJ, Pieters LAC. 1999. New acylated triterpenoid saponins from Maesa lanceolata. Phytochemistry 52: 1121-1131. (Pubitemid 30016476)
4. Bloor SJ, Qi L. 1994. Cytotoxic saponins from New Zealand Myrsine species. J Nat Prod 57: 1354-1360. (Pubitemid 24369951)
5. Cos P, Vlietinck AJ, Vanden Berghe D, Maes L. 2006. Demonstration of anti-infective potential of natural products - how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol 106: 290-302.
6. Croft SL, Sundar S, Fairlamb AH. 2006. Drug resistance in leishmaniasis. Clin Microbiol Rev 19: 111-126.
7. Delmas F, Di Giorgio C, Elias R et al. 2000. Antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro. Planta Med 66: 343-347. (Pubitemid 30346298)
8. Foubert K, Theunis M, Vermeersch M, Apers S, Pieters L, Maes L. 2007. Bioassay-guided isolation of saponins from Apodytes dimidiata. Planta Med 73: 851.
9. Foubert K, Theunis M, Apers S, Vlietinck AJ, Pieters L. 2008a. Chemistry, distribution and biological activities of 13,28-epoxy-oleanane saponins from the plant families Myrsinaceae and Primulaceae. Curr Org Chem 12: 629-642.
10. Foubert K, Vermeersch M, Theunis M et al. In press. LC/MS Analysis of 13,28-epoxy-oleanane saponins in Maesa spp. extracts with antileishmanial activity. Phytochem Anal.
11. Germonprez N, Maes L, Van Puyvelde L, Van Tri M, Tuan DA, De Kimpe N. 2005. In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives. J Med Chem 48: 32-37.
12. Germonprez N, Van Puyvelde L, Maes L, Van Tri M, De Kimpe N. 2004. New pentacyclic triterpene saponins with strong anti-leishmanial activity from the leaves of Maesa balansae. Tetrahedron 60: 219-228. (Pubitemid 38030288)
13. Glénsk M, Wlodarczyk M, Radom M, Cisowski W. 2005. TLC as a rapid and convenient method for saponin investigation. J Planar Chromatogr 18: 167-170.
14. Guerin PJ, Olliaro P, Sundar S et al. 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501. (Pubitemid 34826855)
15. Hegde VR, Silver J, Patel MG et al. 1995. Phospholipase D inhibitors from a Myrsine species . J Nat Prod 58: 1492-1497.
16. Hostettmann K, Marston A. 1995. Saponins, 1st edn. Cambridge University Press: Cambridge.
17. Jia Z, Koike K, Ohmoto T, Nit M. 1994. Triterpenoid saponins from Ardisia crenata. Phytochemistry 37: 1389-1396.
18. Koike K, Kudo M, Jia Z, Nikaido T, Ide Y, Sakura T. 1999. New triterpenoid saponins from Maesa japonica. J Nat Prod 62: 228-232. (Pubitemid 29137894)
19. Kupchan S, Takasugi M, Smith R, Steyn P. 1971. Tumor inhibitors. LXII. The structures of acerotin and acerocin, novel triterpene esters aglycones from the tumor inhibitory saponins of Acer negundo. J Org Chem 36: 1972-1976.
20. Maes L. 2003. Lead Identification and Development of a New Anti-leishmanial Saponin PX-6518, Isolated from the Vietnamese Plant Maesa balansae. PhD thesis. University of Antwerp.
21. Maes L, Germonprez N, Quirijnen L, Van Puyvelde L, Cos P, Vanden Berghe D. 2004a. Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (Ambisome) against Leishmania donovani in hamsters. Antimicrob Agents Chemother 48: 2056-2060. (Pubitemid 38691597)
22. Maes L, Vanden Berghe D, Germonprez N et al. 2004b. In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agents Chemother 48: 130-136.
23. Nwaka S, Hudson A. 2006. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5: 941-955.
24. Okunji CO, Iwu MM, Jackson JE, Tally JD. 1996. Biological activity of saponins from two Dracaena species. Adv Exp Med Biol 404: 415-428. (Pubitemid 26424104)
25. Plock A, Sokolowska-Kohler W, Presber W. 2001. Application of flow cytometry and microscopical methods to characterize the effect of herbal drugs on Leishmania spp. Exp Parasitol 97: 141-153.
26. Podolak I, Elas M, Cieszka K. 1998. In vitro antifungal and cytotoxic activity of triterpene saponosides and quinoid pigments from Lysimachia vulgaris L. Phytother Res 12: S70-S73.
27. Rao AV, Gurfinkel DM. 2000. The bioactivity of saponins: triterpenoid and steroidal glycosides. Drug Metabol Drug Interact 17: 211-235.
28. Sparg SG, Light ME, van Staden J. 2004. Biological activities and distribution of plant saponins. J Ethnopharmacol 94: 219-243.
29. Tschesche R, Wagner R, Widera W. 1983. Saponins from the roots of Primula elatior constitution of minor saponin and revision of the sugar chain of the main saponin. Liebigs Ann Chem 6: 993-1000.
30. van Blitterswijk WJ, Verheij M. 2008. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des 14: 2061-2074.